Introducing The Safe Entry Station
Predictmedix is leading the way with Safe Entry Stations to screen for infectious diseases. Autonomous, quick, non-invasive, no-contact solutions detect symptoms before they spread through your workplace. All it takes is a simple walk-through.
See How Safe Entry Works
Learn how the Safe Entry Station comprehensively screens for infectious diseases without any contact.
More Than Just a Temperature Check
We screen for a host of symptoms, not just one.



Frequently Asked Questions
Recent Press
Predictmedix AI Executives Departing This Weekend for Strategic Collaborations in India
Toronto, Ontario – September 20, 2023– Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today announced that visas have been granted for a strategic visit to India. The primary purpose of the company’s executives’ visit is to engage with institutional partners and government officials in India, with a keen focus on […]
Predictmedix AI Showcased in Toronto Star Newspaper; Accelerates Oxygen Saturation Parameter to Accommodate Widespread Respiratory Health Issues
Toronto, Ontario – September 12, 2023– Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) is proud to announce its recent feature in the prestigious Toronto Star newspaper, accompanied by a compelling interview with the company’s COO, Dr. Rahul Kushwah. This exciting development marks a significant milestone in Predictmedix’s journey, enhancing the […]
Predictmedix AI's 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion
Predictmedix AI’s 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion Toronto, Ontario – September 6, 2023– Predictmedix AI Inc. (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP) (the “Company” or “Predictmedix”) today provided an update on its achievements and developments so far in 2023. Predictmedix AI, a leader in AI-driven healthcare solutions, has achieved remarkable milestones and […]